These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 29410001)

  • 1. Preparation, characterization and efficacy of lysostaphin-chitosan gel against Staphylococcus aureus.
    Nithya S; Nimal TR; Baranwal G; Suresh MK; C P A; Anil Kumar V; Gopi Mohan C; Jayakumar R; Biswas R
    Int J Biol Macromol; 2018 Apr; 110():157-166. PubMed ID: 29410001
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Rapid Lysostaphin Production Approach and a Convenient Novel Lysostaphin Loaded Nano-emulgel; As a Sustainable Low-Cost Methicillin-Resistant
    Nour El-Din HT; Elhosseiny NM; El-Gendy MA; Mahmoud AA; Hussein MMM; Attia AS
    Biomolecules; 2020 Mar; 10(3):. PubMed ID: 32178236
    [No Abstract]   [Full Text] [Related]  

  • 3. Development of Chitosan-Based Hydrogel Containing Antibiofilm Agents for the Treatment of Staphylococcus aureus-Infected Burn Wound in Mice.
    Chhibber T; Gondil VS; Sinha VR
    AAPS PharmSciTech; 2020 Jan; 21(2):43. PubMed ID: 31897806
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of chitosan-collagen hydrogel incorporated with lysostaphin (CCHL) burn dressing with anti-methicillin-resistant Staphylococcus aureus and promotion wound healing properties.
    Cui F; Li G; Huang J; Zhang J; Lu M; Lu W; Huan J; Huang Q
    Drug Deliv; 2011 Apr; 18(3):173-80. PubMed ID: 20726806
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-staphylococcal Activity of Injectable Nano Tigecycline/Chitosan-PRP Composite Hydrogel Using Drosophila melanogaster Model for Infectious Wounds.
    Nimal TR; Baranwal G; Bavya MC; Biswas R; Jayakumar R
    ACS Appl Mater Interfaces; 2016 Aug; 8(34):22074-83. PubMed ID: 27508491
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of Lysostaphin functionalized silicon catheter for the prevention of Staphylococcus aureus biofilm.
    Jayakumar J; Vinod V; Arumugam T; Sathy BN; Biswas L; Kumar VA; Biswas R
    Int J Biol Macromol; 2024 Jan; 256(Pt 2):128547. PubMed ID: 38048926
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo efficacy of the antimicrobial peptide ranalexin in combination with the endopeptidase lysostaphin against wound and systemic meticillin-resistant Staphylococcus aureus (MRSA) infections.
    Desbois AP; Gemmell CG; Coote PJ
    Int J Antimicrob Agents; 2010 Jun; 35(6):559-65. PubMed ID: 20206480
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lysostaphin disrupts Staphylococcus aureus and Staphylococcus epidermidis biofilms on artificial surfaces.
    Wu JA; Kusuma C; Mond JJ; Kokai-Kun JF
    Antimicrob Agents Chemother; 2003 Nov; 47(11):3407-14. PubMed ID: 14576095
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PLGA nanoparticle-encapsulated lysostaphin for the treatment of Staphylococcus aureus infections.
    Landa G; Aguerri L; Irusta S; Mendoza G; Arruebo M
    Int J Biol Macromol; 2024 Jun; 271(Pt 1):132563. PubMed ID: 38782313
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibiofilm activity of chitosan/epsilon-poly-L-lysine hydrogels in a porcine ex vivo skin wound polymicrobial biofilm model.
    Pati BA; Kurata WE; Horseman TS; Pierce LM
    Wound Repair Regen; 2021 Mar; 29(2):316-326. PubMed ID: 33480137
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lysostaphin eradicates established Staphylococcus aureus biofilms in jugular vein catheterized mice.
    Kokai-Kun JF; Chanturiya T; Mond JJ
    J Antimicrob Chemother; 2009 Jul; 64(1):94-100. PubMed ID: 19398455
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hydrogel delivery of lysostaphin eliminates orthopedic implant infection by
    Johnson CT; Wroe JA; Agarwal R; Martin KE; Guldberg RE; Donlan RM; Westblade LF; García AJ
    Proc Natl Acad Sci U S A; 2018 May; 115(22):E4960-E4969. PubMed ID: 29760099
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of activity of recombinant lysostaphin against isolates of meticillin-resistant Staphylococcus aureus from Indian hospitals.
    Kumar A; Khan IA; Sharma PR; K S; Ella KM
    J Med Microbiol; 2014 May; 63(Pt 5):763-766. PubMed ID: 24623634
    [No Abstract]   [Full Text] [Related]  

  • 14. Surface disinfection properties of the combination of an antimicrobial peptide, ranalexin, with an endopeptidase, lysostaphin, against methicillin-resistant Staphylococcus aureus (MRSA).
    Desbois AP; Lang S; Gemmell CG; Coote PJ
    J Appl Microbiol; 2010 Feb; 108(2):723-30. PubMed ID: 19709343
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chitosan derivatives co-delivering nitric oxide and methicillin for the effective therapy to the methicillin-resistant S. aureus infection.
    Liu S; Cai X; Xue W; Ma D; Zhang W
    Carbohydr Polym; 2020 Apr; 234():115928. PubMed ID: 32070544
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic applications of lysostaphin against Staphylococcus aureus.
    Jayakumar J; Kumar VA; Biswas L; Biswas R
    J Appl Microbiol; 2021 Sep; 131(3):1072-1082. PubMed ID: 33382154
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibacterial and antibiofilm surfaces through polydopamine-assisted immobilization of lysostaphin as an antibacterial enzyme.
    Yeroslavsky G; Girshevitz O; Foster-Frey J; Donovan DM; Rahimipour S
    Langmuir; 2015 Jan; 31(3):1064-73. PubMed ID: 25547537
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insights into chitosan antibiofilm activity against methicillin-resistant Staphylococcus aureus.
    Costa EM; Silva S; Tavaria FK; Pintado MM
    J Appl Microbiol; 2017 Jun; 122(6):1547-1557. PubMed ID: 28370752
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lysostaphin: an antistaphylococcal agent.
    Kumar JK
    Appl Microbiol Biotechnol; 2008 Sep; 80(4):555-61. PubMed ID: 18607587
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of methicillin-resistant Staphylococcus aureus in neonatal mice: lysostaphin versus vancomycin.
    Placencia FX; Kong L; Weisman LE
    Pediatr Res; 2009 Apr; 65(4):420-4. PubMed ID: 19127212
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.